Literature DB >> 9878734

Riboflavin-mediated delivery of a macromolecule into cultured human cells.

S R Holladay1, Z Yang, M D Kennedy, C P Leamon, R J Lee, M Jayamani, T Mason, P S Low.   

Abstract

Cell surface receptors for the vitamins folic acid and biotin have been previously reported to mediate the endocytosis of vitamin-conjugated macromolecules into cultured cells. To evaluate whether a similar uptake pathway for riboflavin-conjugated macromolecules might exist, riboflavin was covalently linked to bovine serum albumin (BSA) via the vitamin's ribityl side chain, and uptake of the protein by cultured human cells was examined. Whereas unconjugated BSA was not internalized by KB, A549, SK-LU-1 or SK-OV cells, riboflavin-conjugated BSA was readily internalized (>106 molecules/cell). Analysis of the uptake pathway revealed that the riboflavin-BSA conjugate likely docks on cells at a carrier/transport protein that is distinct from the uptake pathway for free riboflavin and then enters via normal membrane cycling. Evidence for this contention is: (i) the internalized conjugate accumulates in endosomal compartments, (ii) uptake into cells is halted at temperatures near 0 degreesC where membrane trafficking is abrogated, (iii) cell association is inhibited by unlabeled riboflavin-BSA, but not by free riboflavin, and (iv) cellular uptake of [3H]riboflavin is only partially inhibited by riboflavin-BSA. Regardless of the pathway of internalization, these data demonstrate that riboflavin conjugation can facilitate protein entry into human cells in culture.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9878734     DOI: 10.1016/s0304-4165(98)00147-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

Review 1.  Endocytic mechanisms for targeted drug delivery.

Authors:  Lisa M Bareford; Peter W Swaan
Journal:  Adv Drug Deliv Rev       Date:  2007-06-28       Impact factor: 15.470

2.  Characterization of protein factor(s) in rat bronchoalveolar lavage fluid that enhance insulin transport via transcytosis across primary rat alveolar epithelial cell monolayers.

Authors:  Rana Bahhady; Kwang-Jin Kim; Zea Borok; Edward D Crandall; Wei-Chiang Shen
Journal:  Eur J Pharm Biopharm       Date:  2008-02-06       Impact factor: 5.571

3.  cAMP-Coupled riboflavin trafficking in placental trophoblasts: a dynamic and ordered process.

Authors:  Vanessa M D'Souza; Amy B Foraker; R Benjamin Free; Abhijit Ray; Paul S Shapiro; Peter W Swaan
Journal:  Biochemistry       Date:  2006-05-16       Impact factor: 3.162

4.  Bioanalytical Screening of Riboflavin Antagonists for Targeted Drug Delivery - A Thermodynamic and Kinetic Study.

Authors:  Anna Plantinga; Amanda Witte; Ming-Hsin Li; Andrew Harmon; Seok Ki Choi; Mark M Banaszak Holl; Bradford G Orr; James R Baker; Kumar Sinniah
Journal:  ACS Med Chem Lett       Date:  2011-05-12       Impact factor: 4.345

5.  Biophysical characterization of a riboflavin-conjugated dendrimer platform for targeted drug delivery.

Authors:  Amanda B Witte; Christine M Timmer; Jeremy J Gam; Seok Ki Choi; Mark M Banaszak Holl; Bradford G Orr; James R Baker; Kumar Sinniah
Journal:  Biomacromolecules       Date:  2012-01-18       Impact factor: 6.988

6.  Design of riboflavin-presenting PAMAM dendrimers as a new nanoplatform for cancer-targeted delivery.

Authors:  Thommey P Thomas; Seok Ki Choi; Ming-Hsin Li; Alina Kotlyar; James R Baker
Journal:  Bioorg Med Chem Lett       Date:  2010-07-08       Impact factor: 2.823

7.  Recognition of riboflavin and the capsular polysaccharide of Haemophilus influenzae type b by antibodies generated to the haptenic epitope D-ribitol.

Authors:  G Ravi; Yeldur P Venkatesh
Journal:  Glycoconj J       Date:  2014-03-19       Impact factor: 2.916

Review 8.  Riboflavin-Targeted Drug Delivery.

Authors:  Milita Darguzyte; Natascha Drude; Twan Lammers; Fabian Kiessling
Journal:  Cancers (Basel)       Date:  2020-01-27       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.